Literature DB >> 3708816

Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities.

S A Sonder, J W Fenton.   

Abstract

To assess the thrombin specificity of tripeptide chromogenic substrates, we determined the Michaelis--Menten (Km), catalytic (kcat), and specificity (kcat/Km) constants for S-2238 (H-D-Phe-Pip-Arg-p-nitroanilide), Chromozym-TH (Tos-Gly-Pro-Arg-p-nitroanilide), and Spectrozyme-TH (H-D-hexahydrotyrosyl-Ala-Arg-p-nitroanilide) with high-purity thrombin preparations. Human and bovine alpha-thrombins, prepared by essentially the same procedure, were each greater than 95% in the form of the enzyme (alpha-thrombin) and had a specific fibrinogen-clotting activity greater than 2000 kilo-clotting units per gram of protein (kcu/g). In contrast, human gamma- and bovine beta-thrombins, made by controlled passage of alpha-thrombin through trypsin agarose, were greater than 98% of their respective forms and had fibrinogen-clotting activity less than 1 kcu/g. With the tripeptide chromogenic substrates these four thrombin forms at pH 7.8 and 23 degrees C had Km values of 1.6 to 16 mol/L, kcat values of 35 to 130 s-1, and kcat/Km ratios of 4.7 to 52 L X mol-1 X s-1. Although Km for an individual substrate was slightly higher for bovine than for human alpha-thrombins and although Km values for the nonclotting forms (human gamma- and bovine beta-thrombins) were higher than for clotting forms (alpha-thrombins), we found no major differences among the kinetic values for the three substrates.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708816

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids.

Authors:  Brian L Henry; Bernhard H Monien; Paul E Bock; Umesh R Desai
Journal:  J Biol Chem       Date:  2007-09-05       Impact factor: 5.157

2.  Catalytically competent human and bovine zeta-thrombin and chimeras generated from unfolded polypeptide chains.

Authors:  S D Lewis; D V Brezniak; J W Fenton; J A Shafer
Journal:  Protein Sci       Date:  1992-08       Impact factor: 6.725

3.  TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation.

Authors:  Jeremy P Wood; Helle H Petersen; Bingke Yu; Xiaoai Wu; Ida Hilden; Alan E Mast
Journal:  Blood Adv       Date:  2017-12-26

4.  Characterization of thrombin derived from human recombinant prothrombin.

Authors:  Ann Lövgren; Johanna Deinum; Steffen Rosén; Pia Bryngelhed; Per Rosén; Kenny M Hansson
Journal:  Blood Coagul Fibrinolysis       Date:  2015-07       Impact factor: 1.276

5.  Thrombin inhibitory activity of some polyphenolic compounds.

Authors:  M Bijak; R Ziewiecki; J Saluk; M Ponczek; I Pawlaczyk; H Krotkiewski; B Wachowicz; P Nowak
Journal:  Med Chem Res       Date:  2013-10-16       Impact factor: 1.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.